Su1857 - Emergency Department Utilization for Inflammatory Bowel Disease from 2006-2014
Sarah Ballou(Beth Israel Deaconess Medical Center), Anthony Lembo(Cleveland Clinic), William Hirsch(Beth Israel Deaconess Medical Center), Johanna Iturrino-Moreda(Beth Israel Deaconess Medical Center), Sarah N. Flier, Thomas Sommers(Hadassah Medical Center), Adam S. Cheifetz(Beth Israel Deaconess Medical Center), Alan C. Moss(Action Against Medical Accidents), Vikram Rangan(Beth Israel Deaconess Medical Center), Neil Sengupta(Beth Israel Deaconess Medical Center), Prashant Singh(Michigan Medicine), Julia Zubiago(Beth Israel Deaconess Medical Center), Andrea Bollom(Harvard University), Judy Nee(Beth Israel Deaconess Medical Center)
Cited by 0
Related Papers
Bowel Disorders
|Gastroenterology|2016|2.8k
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
|PLoS ONE|2010|910
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696